Humana (NYSE: HUM) reported Q2 EPS of $1.67, $0.04 better than the analyst estimate of $1.63. Revenue for the quarter came in at $13.73 billion versus the consensus estimate of $13.81 billion.

Reaffirmed full-year 2015 EPS guidance of approximately $9.28 or $7.75 on an Adjusted basis (excluding the year-to-date gain on sale of Concentra of $1.53 per share)

For earnings history and earnings-related data on Humana (HUM ) click here.